ArticleFrontiers in neurology2025
Deep learning-based automated segmentation for the quantitative diagnosis of cerebral small vessel disease via multisequence MRI.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Accuracy of Deep Learning in Detecting Cerebral Microbleeds: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Magnetic Resonance Imaging in Cerebral Small Vessel Disease-Related Depression: From Visual Scoring to Artificial Intelligence.CNS neuroscience & therapeutics · 2026Review
- Deep medullary veins score is associated with idiopathic normal pressure hydrocephalus in patients with arteriolosclerotic cerebral small vessel disease.Frontiers in neuroscience · 2026Article
- Artificial intelligence for white matter hyperintensity segmentation: performance, determinants, and clinical implications.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Existing visual scoring systems for cerebral small vessel disease (CSVD) cannot assess the global lesion load accurately and quantitatively. We aimed to develop an automated segmentation method based on deep learning (DL) to quantify the typical neuroimaging markers of CSVD on multisequence magnetic resonance imaging (MRI). Materials and methods: MRI scans from internal (July 2018 to July 2022) and external (November 2012 to January 2015) datasets were analyzed. A DL-based segmentation method was developed to evaluate the quantitative volumes of white matter hyperintensity (WMH), cerebral microbleeds (CMBs), lacunes, and enlarged perivascular spaces (EPVSs) according to the segmentation results. Dice and other quantitative metrics were used to access the DL segmentation results. Pearson correlation coefficients were used for correlation analysis, and the differences in marker volumes among different visual scores were assessed via analysis of variance (ANOVA). Finally, a quantitative Z score was calculated to represent CSVD-related brain burden. Results: A total of 105 internal patients (64.8 ± 7.4 years, 70 males) and 58 external patients (68.2 ± 6.8 years, 29 males) were evaluated. The Dice values for WMH, CMBs, lacunes, and EPVSs in the internal dataset were 0.85, 0.74, 0.76, and 0.75, respectively. The positive correlation between the DL and the manual approach results was excellent (overall Pearson correlation = 0.968, 0.978, 0.948, and 0.947, respectively). The predicted volumes of the CSVD neuroimaging markers showed significant differences among the groups with different visual scores ( Conclusion: An automated DL model was developed for the segmentation of four CSVD neuroimaging markers on multisequence MRI, providing a strong basis for further CSVD research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.